ArticleCancer letters2016

Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.

Jesse Gore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.